SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZATELLI, Maria Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.880
AS - Asia 11.023
EU - Europa 6.963
SA - Sud America 1.935
AF - Africa 195
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 12
Totale 42.024
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.417
SG - Singapore 4.781
CN - Cina 3.141
DE - Germania 1.866
BR - Brasile 1.641
IT - Italia 1.142
UA - Ucraina 1.141
HK - Hong Kong 1.123
GB - Regno Unito 686
TR - Turchia 671
VN - Vietnam 572
FI - Finlandia 494
RU - Federazione Russa 460
SE - Svezia 319
PL - Polonia 286
MX - Messico 211
CA - Canada 205
ID - Indonesia 176
IN - India 138
AR - Argentina 134
FR - Francia 133
NL - Olanda 103
ZA - Sudafrica 100
BD - Bangladesh 76
JP - Giappone 74
ES - Italia 69
AT - Austria 61
IQ - Iraq 54
BE - Belgio 52
EC - Ecuador 45
LT - Lituania 43
PK - Pakistan 42
MA - Marocco 25
CO - Colombia 24
VE - Venezuela 24
UZ - Uzbekistan 20
PY - Paraguay 19
KE - Kenya 16
UY - Uruguay 16
CL - Cile 15
IE - Irlanda 14
CZ - Repubblica Ceca 13
DO - Repubblica Dominicana 13
EG - Egitto 13
AE - Emirati Arabi Uniti 12
AU - Australia 12
IL - Israele 12
IR - Iran 12
MY - Malesia 11
NP - Nepal 11
CH - Svizzera 10
EU - Europa 10
SA - Arabia Saudita 10
DZ - Algeria 9
JO - Giordania 9
KR - Corea 9
PE - Perù 9
TN - Tunisia 9
AL - Albania 8
DK - Danimarca 7
JM - Giamaica 7
LV - Lettonia 7
PH - Filippine 7
RO - Romania 7
BG - Bulgaria 6
BO - Bolivia 6
OM - Oman 6
PT - Portogallo 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
PA - Panama 5
AM - Armenia 4
BH - Bahrain 4
CR - Costa Rica 4
GR - Grecia 4
GT - Guatemala 4
HN - Honduras 4
KG - Kirghizistan 4
KH - Cambogia 4
KZ - Kazakistan 4
LB - Libano 4
NG - Nigeria 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
GA - Gabon 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
MK - Macedonia 3
RS - Serbia 3
SN - Senegal 3
BJ - Benin 2
BY - Bielorussia 2
ET - Etiopia 2
LU - Lussemburgo 2
MD - Moldavia 2
ML - Mali 2
Totale 41.992
Salva come PNG Salva come JPEG
Città #
Singapore 2.709
Ashburn 2.588
Woodbridge 2.085
Fairfield 1.883
Chandler 1.487
Jacksonville 1.266
Houston 1.237
Santa Clara 1.123
Hong Kong 1.116
Beijing 1.047
Ann Arbor 842
Seattle 753
Wilmington 708
Cambridge 626
Izmir 409
Los Angeles 394
Nanjing 374
Dallas 370
Munich 362
New York 315
Princeton 313
Warsaw 283
Addison 276
Ferrara 244
Ho Chi Minh City 201
Milan 195
Boardman 185
San Diego 184
Shanghai 178
São Paulo 177
Mexico City 154
Jakarta 138
Hanoi 125
Turku 122
Helsinki 121
Shenyang 119
Nanchang 111
Dearborn 100
London 96
Bremen 92
Hefei 88
Hebei 85
Brooklyn 82
Chicago 82
Tianjin 81
Montreal 79
Denver 76
Buffalo 71
Moscow 70
Changsha 69
Tokyo 67
Orem 61
Washington 61
Boston 60
Johannesburg 59
Chennai 58
Atlanta 57
Mountain View 56
Phoenix 56
Stockholm 56
Toronto 56
Jiaxing 55
Falls Church 52
Jinan 52
Rome 52
Bologna 49
Frankfurt am Main 47
San Francisco 46
Nuremberg 45
Poplar 45
Rio de Janeiro 45
The Dalles 45
Brussels 44
Kunming 44
Falkenstein 43
Redwood City 38
Belo Horizonte 37
Manchester 36
Norwalk 36
Guangzhou 35
Ankara 34
Council Bluffs 34
Amsterdam 29
Tappahannock 29
Campinas 28
Orange 26
Baghdad 25
Brasília 25
Ningbo 25
Porto Alegre 25
San Mateo 23
Auburn Hills 22
Curitiba 22
Hải Dương 22
Vienna 21
Biên Hòa 20
Da Nang 20
Des Moines 20
Lappeenranta 20
Mumbai 20
Totale 27.874
Salva come PNG Salva come JPEG
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 396
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 285
Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients 255
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 240
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 231
Igf-I influences everolimus activity in medullary thyroid carcinoma 224
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 223
8th edition of the AJCC/TNM staging system of thyroid cancer: What to expect (ITCO#2) 221
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 219
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 218
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 216
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 214
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 212
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 211
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines 207
Increase in Peripheral CD3-CD56brightCD16- Natural Killer Cells in Hashimoto's Thyroiditis Associated with HHV-6 Infection 207
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 206
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 202
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 201
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 198
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 198
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies 197
Adrenal cavernous hemangioma: a case report 196
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 195
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 192
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 191
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 189
Functional characterization of a new deletion in CDKN1B 5'-UTR region 188
Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis 186
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 186
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 186
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 184
The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF 184
Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up. 183
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 182
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 182
Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies 179
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 179
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 177
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 176
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 175
Is there a correlation between BRAFV600 mutation, sentinel lymph node biopsy, pathological and clinical parameters in papillary thyroid carcinoma? 175
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 175
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 174
X-linked acrogigantism syndrome: clinical profile and therapeutic responses 174
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 173
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 173
Growth hormone excess promotes breast cancer chemoresistance 173
Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma 172
Three-Dimensional Primary Cell Culture: A Novel Preclinical Model for Pancreatic Neuroendocrine Tumors 172
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 172
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 171
Should aip gene screening be recommended in family members of FIPA patients with R16H variant? 171
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 171
Presenza di HHV-6 in campioni tiroidei di pazienti con malattie autoimmuni della tiroide 170
Cushing in a Leaf: Endocrine Disruption From a Natural Remedy 170
Antiproliferative effects of somatostatin analogs in pituitary adenomas 169
Effects of two mTOR inhibitors on in-vitro models of GH-secreting pituitary adenomas 169
Growth hormone induces chemoresistance in breast cancer cells 169
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 169
Therapeutic concentrations of mitotane (o,p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model 168
EGF and IGF1 affect sunitinib activity in BP-NEN: New putative targets beyond VEGFR? 168
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 167
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 167
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease 167
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 166
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 166
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 165
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion 165
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 164
miR-15a and miR-16-1 down-regulation in pituitary adenomas 163
HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis 163
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 163
Neck paraganglioma and follicular lymphoma: A case report 163
Pituitary side effects of old and new drugs. 160
mTOR mediated IGF1 proliferative effects on a rat pituitary GH/PRL secreting pituitary adenoma cell line 160
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 159
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 158
A new VHL polymorphism in a big family from Ferrara 158
Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma 158
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 158
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells 157
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH) 157
In vitro testing of new somatostatin analogs on pituitary tumor cells 156
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation 155
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 154
Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury 154
Utilization of luminescent technology to develop a kinase assay: Cdk4 as a model system 154
Cerebral aneurysm and acromegaly: a case report 153
Atypical femoral fractures as a complication of long-term bisphosphonate therapy 153
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 153
Prevalence and predictive factors of anterior hypopituitarism after ischemic stroke. 153
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 152
Cardiac and metabolic effects of chronic GH and IGF1 excess in young adults with pituitary gigantism 152
Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience 151
Levels of p27 sensitize to dual PI3K/mTOR inhibition 151
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 151
An unusual association of hyperparathyroidism, ectopic GHRH secrection and bronchial carcinoid in a MEN1 family 151
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 151
Effects of mTOR inhibitors in the control of non functioning pituitary adenomas cell growth 150
Totale 18.087
Salva come PNG Salva come JPEG
Categoria #
all - tutte 210.794
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 9.836
Totale 220.630
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.989 0 0 0 0 0 341 101 368 98 477 429 175
2021/20222.754 113 256 179 54 118 160 129 151 114 223 266 991
2022/20233.186 321 277 130 435 467 440 168 266 385 26 165 106
2023/20242.076 151 193 103 57 138 315 56 454 58 47 49 455
2024/20257.639 206 165 605 202 929 796 221 311 1.250 974 1.108 872
2025/202611.467 1.974 846 1.797 2.606 3.387 857 0 0 0 0 0 0
Totale 42.587